{"cdcTestId":"2019-0006","testcaseName":"Any dose 26 years, Male, gardasil","vaccineGroup":"HPV","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1996-10-19T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"HPV9","cvx":"165","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2022-11-16T00:00:00","pastDueDate":"2023-02-07T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"HPV9","cvx":"165","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2019-07-01T20:00:00","dateUpdated":"2019-11-14T06:35:05.307","generalDescription":"This test case describes when a male receives the first dose of the HPV vaccine at age 26 years that a second dose should be forecast.","changedInVersion":"4.2","reasonForChange":"v4.2: Added past due date."}